Making BCG vaccination programmes safer in the HIV era
Lancet
.
2008 Sep 6;372(9641):786-7.
doi: 10.1016/S0140-6736(08)61318-5.
Authors
Tippi K Mak
1
,
Anneke C Hesseling
,
Gregory D Hussey
,
Mark F Cotton
Affiliation
1
Department of Public Health and Epidemiology, Swiss Tropical Institute, CH-4002 Basel, Switzerland. tippi.mak@unibas.ch
PMID:
18774406
DOI:
10.1016/S0140-6736(08)61318-5
No abstract available
MeSH terms
AIDS-Related Opportunistic Infections / prevention & control*
BCG Vaccine*
Humans
Infant, Newborn
Risk Assessment
Tuberculosis / prevention & control*
Substances
BCG Vaccine